Current price is more than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Stocks in news: Delhivery, Zomato, Marico, Maruti, Shilpa Medicare, Birlasoft, ONGC and more

Stocks in news: Delhivery, Zomato, Marico, Maruti and more

Shilpa Medicare Q4 Review - Strong Performance; Licensing Fees Lift Margins: ICICI Securities

Shilpa Medicare surged 10.16% to Rs 452 after the drug maker’s consolidated net profit surged 277% to Rs 29.55 crore on a 63.7% jump in net sales to Rs 340.60 crore in Q4 FY22 over Q4 FY21.

Shilpa Medicare rallies after robust Q4 results

Hikal Ltd, eClerx Services Ltd, Sterlite Technologies Ltd and Sharda Cropchem Ltd are among the other gainers in the BSE’s ‘A’ group today, 24 May 2022.

Shilpa Medicare Ltd leads gainers in ‘A’ group

The Company will be submitting the responses to USFDA observations within stipulated timeline and implement the corrective actions to address the observations.

USFDA conducts inspection at Shilpa Medicare’s analytical services division in Hyderabad; Stock down 1%

Listed pharmaceutical entity Shilpa Medicare on Monday informed the exchanges that its subsidiary Shilpa Biologicals (SBPL) has received a NoC from RCGM, Dept of Biotechnology to approach the Drugs Controller General of India (DCGI) to conduct clinical studies for its Biosimilar Aflibercept.

Shilpa Medicare arm gets NoC to conduct clinical studies for its Biosimilar Aflibercept

Listed pharmaceutical firm Shilpa Medicare Ltd is demerging its active pharmaceutical ingredients (API) business into a separate company with the plan to take it public through an initial public offering (IPO) to raise upwards of ₹1,000 crore

Shilpa Medicare demerging API business to take it public

The drugmaker has also entered into a definitive agreement with Shilpa Medicare Ltd, a contract manufacturing organisation, to produce mutually agreeable doses of ZyCoV-D.

Zydus Cadila Starts Supply of Covid-19 Vaccine to Govt

The Ahmedabad-based drugmaker has also entered into a definitive agreement with Shilpa Medicare Ltd, a contract manufacturing organisation, to produce mutually agreeable doses of ZyCoV-D. It has also entered into an agreement with Enzychem Lifesciences of the Republic of Korea for the manufacturing …

Zydus Cadila starts supply of Covid 19 vaccine to govt

Prucalopride is used for symptomatic treatment of chronic constipation in adults in whom laxatives fail to provide adequate relief.

Shilpa Medicare launches PRUCALSHIL (Prucalopride) Orally Disintegrating Strips in India

Shilpa Medicare jumped 4.33% to Rs 551.85 after the drug maker on Tuesday announced the launch of chronic constipation drug in adults.

Shilpa Medicare rises after launching chronic constipation drug

Shilpa Medicare Limited is engaged in the business of manufacturing of bulk drugs or active pharmaceutical ingredient (API) and intermediates, and wind power generation.

Shilpa Medicare Ltd

Shilpa Medicare Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Stocks in news: Delhivery, Zomato, Marico, Maruti and more

Shilpa Medicare Q4 Review - Strong Performance; Licensing Fees Lift Margins: ICICI Securities

Shilpa Medicare rallies after robust Q4 results

Shilpa Medicare Ltd leads gainers in ‘A’ group

USFDA conducts inspection at Shilpa Medicare’s analytical services division in Hyderabad; Stock down 1%

Shilpa Medicare arm gets NoC to conduct clinical studies for its Biosimilar Aflibercept

Shilpa Medicare demerging API business to take it public

Shilpa Medicare Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Stocks in news: Delhivery, Zomato, Marico, Maruti and more

Shilpa Medicare Q4 Review - Strong Performance; Licensing Fees Lift Margins: ICICI Securities

Shilpa Medicare rallies after robust Q4 results

Shilpa Medicare Ltd leads gainers in ‘A’ group

USFDA conducts inspection at Shilpa Medicare’s analytical services division in Hyderabad; Stock down 1%

Shilpa Medicare arm gets NoC to conduct clinical studies for its Biosimilar Aflibercept

Shilpa Medicare demerging API business to take it public

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock